Results 311 to 320 of about 454,627 (348)

Labeling Drug Ampules

Anesthesiology, 1973
openaire   +2 more sources

investigational drug labelling

2009
The package of an investigational new drug intended for human use has to bear a label with a statement specific for the national regulations; EC: name and address of the company, identification of the substance or code, date of expiry/ retest, lot number, name of the responsible physician, to be used for clinical trials; US: “caution: new drug ...
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

LABELLING OF DRUGS

Medical Journal of Australia, 1972
openaire   +2 more sources

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
H S L Jim, Aasha I Hoogland, Naomi C Brownstein   +2 more
exaly  

Drug Trials Snapshots and Sexless Drug Labels

JAMA Internal Medicine, 2017
G Elliott, Cook, Erin E, Wilhelm
openaire   +2 more sources

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly